Genomics raised €28M in a Series B round in Sep 2018. The company is based in Oxford, UK. Investors in the round: Invesco Perpetual, Lansdowne Partners, Oxford Sciences Innovation and 3 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
